Home Articles List Article Information
ALEXMED ePosters
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Yakout, Y. (2021). STUDY OF THE EXPRESSION OF MICRORNA 181A AND ITS TARGET GENES: BCL2 AND NOVA1 IN MULTIPLE MYELOMA. ALEXMED ePosters, 3(2), 5-6. doi: 10.21608/alexpo.2021.62618.1120
Yasmin Wagih Yakout. "STUDY OF THE EXPRESSION OF MICRORNA 181A AND ITS TARGET GENES: BCL2 AND NOVA1 IN MULTIPLE MYELOMA". ALEXMED ePosters, 3, 2, 2021, 5-6. doi: 10.21608/alexpo.2021.62618.1120
Yakout, Y. (2021). 'STUDY OF THE EXPRESSION OF MICRORNA 181A AND ITS TARGET GENES: BCL2 AND NOVA1 IN MULTIPLE MYELOMA', ALEXMED ePosters, 3(2), pp. 5-6. doi: 10.21608/alexpo.2021.62618.1120
Yakout, Y. STUDY OF THE EXPRESSION OF MICRORNA 181A AND ITS TARGET GENES: BCL2 AND NOVA1 IN MULTIPLE MYELOMA. ALEXMED ePosters, 2021; 3(2): 5-6. doi: 10.21608/alexpo.2021.62618.1120

STUDY OF THE EXPRESSION OF MICRORNA 181A AND ITS TARGET GENES: BCL2 AND NOVA1 IN MULTIPLE MYELOMA

Article 79, Volume 3, Issue 2, June 2021, Page 5-6  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2021.62618.1120
View on SCiNiTO View on SCiNiTO
Author
Yasmin Wagih Yakout email
Clinical and Chemical Pathology Department, Faculty of Medicine, Alexandria University, Egypt
Abstract
Multiple myeloma (MM) is a plasma cell neoplasm accounting for 10% of hematological malignancies. It is characterized by clonal proliferation of plasma cells in the bone marrow resulting in monoclonal M-protein production. This ultimately results in end organ damage presenting as: C (Hypercalcemia), R (Renal failure), A (Anemia), B (bone lesions).
MM is characterized by its complex genetic landscape, that tends to change over time owing to additional events, as somatic mutations, epigenetic and chromosomal copy-number changes.
The role of micro-RNAs, small non-coding RNAs, in myelomagenesis has been receiving increasing attention. They are found to manipulate the cross talk between myeloma cells and bone marrow micro-environment and thereby playing their role.
Studies have shown that miR-181a may play a role in lymphocyte proliferation and differentiation into B cells. At the same time, it has been suggested that the expression of miR-181a is increased in MM. The complex relationship between miR-181a and the various clinical and pathological factors of MM disease is yet to be clarified.
Keywords
Multiple myeloma (MM); miR-181a; BCL2 and NOVA1
Supplementary Files
Statistics
Article View: 211